Treatment guided by next generation functional drug screening provides clinical benefit in advanced aggressive hematological malignancies: Final evaluation of the open label, single arm EXALT trial Meeting Abstract


Authors: Kornauth, C.; Pemovska, T.; Vladimer, G. I.; Bayer, G.; Bergmann, M.; Eder, S.; Eichner, R.; Esterbauer, H.; Exner, R.; Felsleitner-Hauer, V.; Forte, M.; Gaiger, A.; Greinix, H. T.; Gstöttner, W.; Hacker, M.; Hauswirth, A.; Heinemann, T.; Heintel, D.; Hoda, M. A. R.; Jaeger, U.; Kazianka, L.; Kenner, L.; Kiesewetter, B.; Krall, N.; Le, T.; Lubowitzki, S.; Mayerhoefer, M. E.; Menschel, E.; Merkel, O.; Miura, K.; Muellauer, L.; Neumeister, P.; Noesslinger, T.; Ocko, K.; Öhler, L.; Panny, M.; Pichler, A.; Porpaczy, E. A.; Prager, G.; Raderer, M.; Ristl, R.; Ruckser, R.; Salamon, J.; Schiefer, A. I.; Schmolke, A. S.; Schwarzinger, I.; Selzer, E.; Skrabs, C.; Sperr, W. R.; Srndic, I.; Thalhammer, R.; Valent, P.; van der Kouwe, E.; Vanura, K.; Vogt, S.; Waldstein, C.; Wolf, D.; Zielinski, C.; Simonitsch-Klupp, I.; Superti-Furga, G.; Snijder, B.; Staber, P. B.
Abstract Title: Treatment guided by next generation functional drug screening provides clinical benefit in advanced aggressive hematological malignancies: Final evaluation of the open label, single arm EXALT trial
Meeting Title: 62nd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 136
Issue: Suppl. 1
Meeting Dates: 2020 Dec 5-8
Meeting Location: Virtual
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2020-11-05
Language: English
ACCESSION: WOS:000607547205017
DOI: 10.1182/blood-2020-140831
PROVIDER: wos
Notes: Meeting Abstract: 2 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors